Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 2, 2013
Reporting Period: Three months ended March 31, 2013
Event: Announcement of financial results for the quarter ended March 31, 2013.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on May 2, 2013, announcing the financial results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, risks, or contingencies are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2013.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Confirm any forward-looking statements or guidance provided in the press release, noting the legal disclaimer regarding the "filed" status of this information.
- Check for any unusual items or non-recurring charges disclosed in the full press release text.